Groundbreaking Study Reveals Potential to Regenerate cartilage and Reverse Osteoarthritis
Table of Contents
A novel treatment targeting a key protein involved in aging has demonstrated the ability to reverse cartilage loss in mice and prevent the growth of arthritis, offering a potential pathway to eliminate the need for knee and hip replacements. The research, lead by scientists at Stanford Medicine, identifies a “gerozyme” – 15-PGDH – as a master regulator of aging and a direct driver of cartilage degeneration.
The findings, published November 27 in Science, suggest that inhibiting 15-PGDH can stimulate cartilage regeneration, even in aged animals and those with injuries mimicking ACL tears. Human cartilage tissue also responded positively to the treatment, exhibiting signs of renewed growth.
The Promise of Targeting 15-PGDH
Osteoarthritis, a debilitating joint disease affecting one in five adults in the United States, currently lacks effective treatments that can slow or reverse its progression. Existing therapies primarily focus on pain management and eventual surgical joint replacement, representing a $65 billion annual healthcare burden. This new research directly addresses the underlying cause of the disease, offering a potentially transformative approach.
Researchers discovered that 15-PGDH, identified as a gerozyme in 2023, increases in prevalence with age and drives the loss of tissue function. Blocking this protein in older mice led to increased muscle mass and endurance. Conversely, increasing 15-PGDH in young mice resulted in muscle weakening. The gerozyme’s influence extends beyond muscle tissue, impacting the regeneration of bone, nerve, and blood cells.
A Novel Mechanism of Cartilage Regeneration
Interestingly, the cartilage regeneration observed in the study doesn’t rely on stem cells, a common focus of regenerative medicine. Instead, existing cartilage cells, called chondrocytes, shift their gene expression patterns to a more youthful state. “This is a new way of regenerating adult tissue, and it has important clinical promise for treating arthritis due to aging or injury,” explained Helen blau, Ph.D., professor of microbiology and immunology at Stanford. “we were looking for stem cells, bu
and break down collagen, the primary structural protein of cartilage. This leads to cartilage thinning, inflammation, and pain.
Under normal circumstances, articular cartilage has limited regenerative capacity. While some stem cell populations capable of cartilage generation have been identified in bone, similar populations haven’t been found within the cartilage itself.
The Role of Prostaglandin E2
Previous research from Blau’s lab established that prostaglandin E2 is essential for muscle stem cell function. 15-PGDH degrades prostaglandin E2, meaning that inhibiting 15-PGDH or increasing prostaglandin E2 levels supports tissue regeneration. The Stanford team hypothesized that this pathway might also be relevant to cartilage aging and injury. Their investigation confirmed a two-fold increase in 15-PGDH levels in the knee cartilage of older mice compared to younger mice.
The researchers also observed a shift in chondrocyte populations after treatment. The prevalence of cells expressing 15-PGDH and genes involved in cartilage degradation decreased, while cells expressing genes involved in hyaline cartilage formation increased. This indicates a reversion to a more youthful cartilage composition without the need for stem cell involvement.
Clinical Trials on the Horizon
Phase 1 clinical trials of a 15-PGDH inhibitor for age-related muscle weakness have already demonstrated the drug’s safety and activity in healthy volunteers. The researchers are optimistic that a similar trial will soon be launched to evaluate its effectiveness in cartilage regeneration. “Imagine regrowing existing cartilage and avoiding joint replacement,” Blau concluded.
More details: mamta Singla et al, Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration, Science (2025). DOI: 10.1126/science.adx6649.www.science.org/doi/10.1126/science.adx6649
